Prepared By R.R. Donnelley Financial -- Form 8-K
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  04/23/2010
 
Unitrin, Inc.
(Exact name of registrant as specified in its charter)
 
Commission File Number:  0-18298
 
DE
  
95-4255452
(State or other jurisdiction of
  
(IRS Employer
incorporation)
  
Identification No.)
 
One East Wacker Drive, Chicago, IL 60601
(Address of principal executive offices, including zip code)
 
312-661-4600
(Registrant’s telephone number, including area code)
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[  ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[  ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[  ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
Item 8.01.    Other Events
 
Unitrin, Inc., the registrant ("Unitrin"), announced today that its previously announced negotiations with Physicians Mutual Insurance Company for the sale of Unitrin's Reserve National Insurance Company subsidiary have been terminated due to a failure by the parties to reach a definitive agreement. Unitrin had announced two months ago that it had reached an agreement in principle to sell Reserve National to Physicians Mutual(R). In connection with this development, Unitrin also announced that it has retained Macquarie Capital to assist it in identifying a suitable alternative buyer for Reserve National. Further information about the transaction and Unitrin is included in the press release issued by Unitrin on April 23, 2010, attached hereto as Exhibit 99.01 and incorported herein by reference.

This report contains information that includes or is based upon forward-looking statements within the meaning of the Federal securities laws. Forward-looking statements give expectations or forecasts of future events, and can be identified by the fact that they relate to future actions, performance or results rather than strictly to historical or current facts. Any or all forward-looking statements may turn out to be wrong, and, accordingly, readers are cautioned not to place undue reliance on such statements. Forward-looking statements involve a number of risks and uncertainties that are difficult to predict, and are not guarantees of future performance. Among the general factors that could cause actual results to differ materially from estimated results are those listed in periodic reports filed by Unitrin with the Securities and Exchange Commission (the "SEC"). No assurances can be given that the results contemplated in any forward-looking statements will be achieved at all or in any particular timetable, and Unitrin assumes no obligation to publicly correct or update any forward-looking statements as a result of any subsequent developments. However, readers are advised to consult any further disclosures Unitrin makes on related subjects in its SEC filings.

 
 
Item 9.01.    Financial Statements and Exhibits
 
Exhibit 99.01 Press Release Dated April 23, 2010
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
           
Unitrin, Inc.
 
 
Date: April 23, 2010
     
By:
 
/s/    Scott Renwick
               
Scott Renwick
               
Senior Vice President
 
 

 

EXHIBIT INDEX
 
Exhibit No.
  
Description
EX-99.01
  
Press Release dated April 23, 2010